A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma
Titel:
A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma
Auteur:
Brittain, Dominic D’Andrea, Peter Gruen, Emilie Hosoe, Motoi Jain, Devendra Jauernig, Juergen Pethe, Abhijit Scosyrev, Emil Tanase, Ana-Maria Tillmann, Hanns-Christian